Status:

UNKNOWN

Perceptual Decision Making Under Conditions of Visual Uncertainty

Lead Sponsor:

University of California, Los Angeles

Collaborating Sponsors:

The Dana Foundation

Conditions:

Parkinson's Disease

Dystonia

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

In this proposal the investigators have three Specific Aims using human patient populations as model systems; 1) identify a role for the Basal Ganglia (BG) in perceptual decision making; 2) determine ...

Detailed Description

In this study, the investigators aim determine whether patients with Parkinson's disease (PD) have altered perceptual decision-making. The results of these experiments will shed important light on som...

Eligibility Criteria

Inclusion

  • Group 1 - Age and Sex matched healthy controls:
  • Age 18-80 Years
  • Group 2 - Patients with Parkinson's Disease - No DBS:
  • "on meds" and "off meds" (tested in separate sessions) - total of 2 sessions
  • Age 45-80 Years
  • Unified PD rating scale (UPDRS)
  • Mini mental health Status (MMHS)
  • Group 3 - Patients with Parkinson's Disease already consented for DBS (STN):
  • Age 45-80 Years
  • Unified PD rating scale (UPDRS)
  • Mini mental health Status (MMHS)
  • Group 4 - Patients with Parkinson's Disease already consented for DBS (GPi):
  • Age 45-80 Years
  • Unified PD rating scale (UPDRS)
  • Mini mental health Status (MMHS)
  • Group 5 - Patients with Cervical Dystonia - No DBS
  • Age 30-80 years
  • Fahn-Marsden dystonia rating scale (FMDRS)
  • Mini mental health Status (MMHS)
  • Group 6 - Patients with Generalized Dystonia (Ach) - No DBS:
  • Age 30-80 years
  • Fahn-Marsden dystonia rating scale (FMDRS)
  • Mini mental health Status (MMHS)
  • Group 7 - Patients with Dystonia already consented for DBS (GPi):
  • Age 30-80 years
  • Fahn-Marsden dystonia rating scale (FMDRS)
  • Mini mental health Status (MMHS)
  • Group 8 - Patients Cerebellar Stroke
  • Age 30-80 Years
  • Routine neuro exam
  • Mini mental health Status (MMHS)
  • Group 9 - Patients Cerebellar Ataxia
  • Age 30-80 Years
  • Routine neuro exam
  • Mini mental health Status (MMHS)

Exclusion

  • Visual impairment or ocular motility disorder Inability to sit for the 30 minute task plus 20-30 minute instruction time, setup, and wait time.
  • For Group 1 (Age Sex Matched Controls), there will additional exclusion criteria of other neurological disease and drug use

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2016

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT01845883

Start Date

April 1 2013

End Date

December 1 2016

Last Update

December 18 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Neuroscience Research Building

Los Angeles, California, United States, 90095